Albert Gilbert
Urology · Columbus, GANPI 1427581313
Payments from drug & device makers
Across 92 payments — averaging $120.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- AbbVie$354
- Procept Biorobotics Corporation$317
- Sumitomo Pharma America, Inc.$305
- Boston Scientific$181
- Myriad Genetic Laboratories, Inc.$179
- plus $784 from 23 others
What the payments were for
- Food & beverage$2,07119%
- Education$9,04881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $9,000 |
| AbbVie | 17 | $354 |
| Procept Biorobotics Corporation | 5 | $317 |
| Sumitomo Pharma America, Inc. | 11 | $305 |
| Boston Scientific | 7 | $181 |
| Myriad Genetic Laboratories, Inc. | 9 | $179 |
| Tolmar, Inc. | 4 | $90 |
| Axonics, Inc. | 3 | $85 |
| Pfizer | 4 | $78 |
| Astellas Pharma US Inc | 2 | $48 |
| Endo USA, Inc. | 2 | $48 |
| ABC Home Medical Supply, Inc. | 2 | $46 |
| Progenics Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca | 1 | $35 |
| Merck | 1 | $31 |
| Tolmar Pharmaceuticals, Inc. | 1 | $26 |
| Blue Earth Diagnostics | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $22 |
| Teleflex LLC | 1 | $22 |
| Coloplast | 1 | $22 |
| Medtronic | 1 | $22 |
| Bayer | 1 | $21 |
| Calyxo, Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| Profound Medical Corp. | 1 | $17 |
| Ambu Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 6 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,000
- ORGOVYX$124
How this compares
$11,119 in reported general payments places this provider in the 75th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 70 | $56,693 |
| GemtesaVibegron | 20 | $19,821 |
| Tolterodine Tartrate ErTolterodine Tartrate | 40 | $4,859 |
| Tamsulosin Hcl | 261 | $3,244 |
| Estradiol | 38 | $1,986 |
| Trospium Chloride | 23 | $1,984 |
| Finasteride | 122 | $1,437 |
| Testosterone | 14 | $1,308 |
| Oxybutynin Chloride ErOxybutynin Chloride | 32 | $1,117 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 33 | $800 |
| Testosterone Cypionate | 12 | $517 |
| CefuroximeCefuroxime Axetil | 44 | $417 |
| Terazosin Hcl | 12 | $317 |
| Ibuprofen | 32 | $249 |
| Oxybutynin Chloride | 28 | $198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $48 | $56,69370 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $305 | $19,82120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 369 urology providers in Georgia.
Other urology in Columbus
- Elizabeth WendelColumbus$22K
- Vahan KassabianRoswell$3M
- Viraj MasterAtlanta$2M
- Vikram NarayanAtlanta$1.1M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$611K
- Kenneth OganAtlanta$425K
- Jason LomboyMarietta$280K
- Syed JafriDecatur$177K
- Jeffrey ProctorCartersville$167K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.